QC
DTIL icon

Quent Capital’s Precision BioSciences DTIL Stock Holding History

Quent Capital’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3
Closed -$57 – 1330
2023
Q1 		$57 Hold
3
– – ﹤0.01% 1306
2022
Q4 		$90 Hold
3
– – ﹤0.01% 1291
2022
Q3 		$0 Hold
3
– – ﹤0.01% 1228
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1204
2022
Q1 		$0 Buy
+3
New +$408 ﹤0.01% 1275

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Quent Capital's DTIL Position: Q2 2023 in Review

Quent Capital sold out of Precision BioSciences (DTIL) in Q2 2023, closing a stake of 3 shares — an estimated $57 sold.

Quent Capital first reported a position in DTIL in Q1 2022 and held it in 5 quarters. The position peaked at $90 in Q4 2022. 77 funds tracked by Wall St. Rank hold DTIL as of Q2 2023.

  • Quent Capital reported no remaining Precision BioSciences position as of Q2 2023 after selling out during the quarter.
  • Quent Capital sold 3 Precision BioSciences shares in Q2 2023, an estimated $57.
  • Quent Capital first reported a position in Precision BioSciences in Q1 2022 and held it in 5 quarters.
  • Quent Capital's Precision BioSciences position peaked at $90 in Q4 2022.
  • 77 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2023.

Based on Quent Capital's 13F filing for Q2 2023, filed 10 Jul 2023.